A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis

NCT00001422 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

NIH

Sponsor class

Conditions

Arthritis, Psoriatic
Psoriasis

Interventions

DRUG: fludarabine

Sponsor

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)